.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Teva
Chubb
Merck
Deloitte
Moodys
US Department of Justice
UBS
Boehringer Ingelheim
McKesson

Generated: June 24, 2017

DrugPatentWatch Database Preview

DISPERMOX Drug Profile

« Back to Dashboard

What is the patent landscape for Dispermox, and what generic Dispermox alternatives are available?

Dispermox is a drug marketed by Ranbaxy Labs Ltd and is included in two NDAs.

The generic ingredient in DISPERMOX is amoxicillin. There are forty-four drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

Summary for Tradename: DISPERMOX

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list37
Patent Applications: see list7,823
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DISPERMOX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs Ltd
DISPERMOX
amoxicillin
TABLET, FOR SUSPENSION;ORAL065159-001Dec 4, 2003DISCNNoNo► Subscribe► Subscribe
Ranbaxy Labs Ltd
DISPERMOX
amoxicillin
TABLET, FOR SUSPENSION;ORAL065080-002Aug 11, 2003DISCNNoNo► Subscribe► Subscribe
Ranbaxy Labs Ltd
DISPERMOX
amoxicillin
TABLET, FOR SUSPENSION;ORAL065080-001Aug 11, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Teva
Colorcon
UBS
Boehringer Ingelheim
Chinese Patent Office
Chubb
Cerilliant
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot